Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K May 22, 2025 10-K
8-K May 22, 2025 FORM 8-K
SCHEDULE 13G/A May 15, 2025
S-8 Apr 25, 2025 FORM S-8
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
4 Apr 3, 2025 OWNERSHIP DOCUMENT
S-8 Mar 14, 2025 FORM S-8
SCHEDULE 13D Mar 7, 2025
3 Mar 7, 2025 3
4 Mar 7, 2025 4
3 Mar 7, 2025 3
8-K Mar 7, 2025 FORM 8-K
UPLOAD Feb 20, 2025
SCHEDULE 13G/A Feb 14, 2025
S-8 Feb 12, 2025 FORM S-8
← Newer Page 6 of 27 · 669 filings Older →